Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionPrelude Capital Management, Llc
Latest Disclosed Ownership1,783 shares
Latest Disclosed Value $ 248,497
Prelude Capital Management, Llc ownership in GILD / Gilead Sciences, Inc.

On May 15, 2026 - Prelude Capital Management, Llc filed a 13F-HR form disclosing ownership of 1,783 shares of Gilead Sciences, Inc. (CH:GILD) valued at $248,497 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 14, 2025 disclosing 0 shares of Gilead Sciences, Inc..

Prelude Capital Management, Llc has a history of taking positions in derivatives of the underlying security (GILD) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CH:GILD / Gilead Sciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM 375558103 1,783 1,783 248 0.0190
2025-11-14 2025-09-30 13F GILEAD SCIENCES COM 375558103 0 -9,264 -100.00 0 -100.00
2025-08-14 2025-06-30 13F GILEAD SCIENCES COM 375558103 9,264 6,803 276.43 1,027 273.45 0.0999
2025-05-15 2025-03-31 13F GILEAD SCIENCES COM 375558103 2,461 -8,099 -76.70 276 -71.79 0.0210
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM 375558103 10,560 -3,920 -27.07 975 -19.69 0.0611
2024-11-14 2024-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 14,480 14,480 1,214 0.0734
2024-11-14 2024-09-30 13F GILEAD SCIENCES COM 375558103 14,480 14,480 1,214 0.0455
2022-08-24 2022-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 0 -5,488 -100.00 0 -100.00
2022-08-15 2022-06-30 13F GILEAD SCIENCES COM 375558103 0 -5,488 0
2022-05-16 2022-03-31 13F GILEAD SCIENCES COM 375558103 5,488 -12,467 -69.43 326 -75.00 0.0094
2022-02-14 2021-12-31 13F GILEAD SCIENCES COM 375558103 17,955 17,955 1,304 0.0334
2021-08-16 2021-06-30 13F GILEAD SCIENCES COM 375558103 0 -22,921 -100.00 0 -100.00
2021-05-17 2021-03-31 13F GILEAD SCIENCES COM 375558103 22,921 14,875 184.87 1,481 215.78 0.0381
2021-02-16 2020-12-31 13F GILEAD SCIENCES COM 375558103 8,046 1,106 15.94 469 6.83 0.0119
2020-11-16 2020-09-30 13F GILEAD SCIENCES COM 375558103 6,940 -1,317 -15.95 439 -30.87 0.0212
2020-08-14 2020-06-30 13F GILEAD SCIENCES COM 375558103 8,257 -15,779 -65.65 635 -64.66 0.0350
2020-05-15 2020-03-31 13F GILEAD SCIENCES COM 375558103 24,036 11,220 87.55 1,797 115.73 0.1204
2020-02-14 2019-12-31 13F GILEAD SCIENCES COM 375558103 12,816 12,816 -46.68 833 -53.64 0.0317
2019-11-14 2019-09-30 13F GILEAD SCIENCES COM 375558103 0 -29,524 -100.00 0 -100.00
2019-08-14 2019-06-30 13F GILEAD SCIENCES COM 375558103 29,524 6,401 27.68 1,995 32.73 0.0981
2019-05-15 2019-03-31 13F GILEAD SCIENCES COM 375558103 23,123 -19,436 -45.67 1,503 -43.54 0.0847
2019-02-14 2018-12-31 13F GILEAD SCIENCES COM 375558103 42,559 22,769 115.05 2,662 74.21 0.1783
2018-11-14 2018-09-30 13F GILEAD SCIENCES COM 375558103 19,790 -2,654 -11.82 1,528 -3.90 0.0887
2018-08-14 2018-06-30 13F GILEAD SCIENCES COM 375558103 22,444 17,432 347.81 1,590 320.63 0.1006
2018-05-15 2018-03-31 13F GILEAD SCIENCES COM 375558103 5,012 -8,002 -61.49 378 -59.44 0.0275
2018-02-14 2017-12-31 13F GILEAD SCIENCES COM 375558103 13,014 3,648 38.95 932 22.79 0.0748
2017-11-14 2017-09-30 13F GILEAD SCIENCES COM 375558103 9,366 -33,437 -78.12 759 -74.95 0.0684
2017-08-14 2017-06-30 13F GILEAD SCIENCES COM 375558103 42,803 6,377 17.51 3,030 22.47 0.2868
2017-05-15 2017-03-31 13F GILEAD SCIENCES COM 375558103 36,426 7,650 26.58 2,474 20.04 0.2367
2017-02-14 2016-12-31 13F GILEAD SCIENCES COM 375558103 28,776 2,044 7.65 2,061 -2.55 0.2490
2016-11-14 2016-09-30 13F GILEAD SCIENCES COM 375558103 26,732 -11,645 -30.34 2,115 -33.93 0.2219
2016-08-15 2016-06-30 13F GILEAD SCIENCES COM 375558103 38,377 -851 -2.17 3,201 -11.16 0.4476
2016-05-16 2016-03-31 13F GILEAD SCIENCES COM 375558103 39,228 547 1.41 3,603 -7.95 0.5028
2016-02-16 2015-12-31 13F GILEAD SCIENCES COM 375558103 38,681 3,040 8.53 3,914 11.83 0.6068
2015-11-16 2015-09-30 13F GILEAD SCIENCES COM 375558103 35,641 14,956 72.30 3,500 44.51 0.5086
2015-08-14 2015-06-30 13F GILEAD SCIENCES COM 375558103 20,685 1,338 6.92 2,422 27.54 0.3390
2015-05-15 2015-03-31 13F GILEAD SCIENCES COM 375558103 19,347 546 2.90 1,899 7.17 0.2632
2015-02-13 2014-12-31 13F GILEAD SCIENCES COM 375558103 18,801 -6,400 -25.40 1,772 -33.95 0.2596
2014-11-14 2014-09-30 13F GILEAD SCIENCES COM 375558103 25,201 1,760 7.51 2,683 38.09 0.3778
2014-08-14 2014-06-30 13F GILEAD SCIENCES COM 375558103 23,441 5,670 31.91 1,943 54.33 0.2570
2014-05-15 2014-03-31 13F GILEAD SCIENCES COM 375558103 17,771 -1,750 -8.96 1,259 -14.12 0.1687
2014-02-14 2013-12-31 13F GILEAD SCIENCES COM 375558103 19,521 2,000 11.41 1,466 33.03 0.2419
2013-11-14 2013-09-30 13F GILEAD SCIENCES COM 375558103 17,521 -14,193 -44.75 1,102 -32.23 0.1779
2013-08-14 2013-06-30 13F GILEAD SCIENCES COM 375558103 31,714 -6,300 -16.57 1,626 -12.58 0.3489
2013-05-22 2013-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 38,014 38,014 1,860 0.3468
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-05-17 2021-03-31 13F GILEAD SCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F GILEAD SCIENCES COM Call 22,700 1,323 n/a n/a n/a
2020-11-16 2020-09-30 13F GILEAD SCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-14 2020-06-30 13F GILEAD SCIENCES COM Call 5,100 1,175.00 392 1,206.67 n/a n/a n/a
2020-05-15 2020-03-31 13F GILEAD SCIENCES COM Call 400 -55.56 30 -48.28 n/a n/a n/a
2020-02-14 2019-12-31 13F GILEAD SCIENCES COM Call 900 125.00 58 93.33 n/a n/a n/a
2019-08-14 2019-06-30 13F GILEAD SCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-15 2019-03-31 13F GILEAD SCIENCES COM Call 400 26 n/a n/a n/a
2014-08-14 2014-06-30 13F GILEAD SCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-05-15 2014-03-31 13F GILEAD SCIENCES COM Call 1,500 106 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-05-15 2020-03-31 13F GILEAD SCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F GILEAD SCIENCES COM Put 16,300 1,059 n/a n/a n/a
2019-11-14 2019-09-30 13F GILEAD SCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-14 2019-06-30 13F GILEAD SCIENCES COM Put 40,000 -20.00 2,702 -16.89 n/a n/a n/a
2019-05-15 2019-03-31 13F GILEAD SCIENCES COM Put 50,000 25.00 3,251 29.94 n/a n/a n/a
2019-02-14 2018-12-31 13F GILEAD SCIENCES COM Put 40,000 -20.00 2,502 -23.04 n/a n/a n/a
2018-11-14 2018-09-30 13F GILEAD SCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-14 2018-06-30 13F GILEAD SCIENCES COM Put 35,000 2,479 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.